K
Kura Oncology
KURA
20.190
USD
-0.63
(-3.03%)
مفتوح الان
حجم التداول
5,911
الربح لكل سهم
0
العائد الربحي
0
P/E
-8
حجم السوق
1,347,234,440
الأخبار
العنوان: Kura Oncology
القطاع: Healthcare
الصناعة: Biotechnology
Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signaling pathways to drive the progression of various cancers. The company has a product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. Geographically operationof the group is carried through the United States.